Navigation Links
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
Date:3/31/2008

the U.S. Food and Drug Administration (FDA), which is expected to occur in the first half of 2008. Upon FDA approval of the PROMUS Stent, Boston Scientific will immediately make it available for sale in the United States.

The PROMUS Stent is an investigational device in the U.S. and not yet approved for sale. The PROMUS Stent is currently for sale in Europe and certain other international markets. TAXUS and PROMUS are trademarks of Boston Scientific Corporation or its affiliates. XIENCE is a trademark of the Abbott Laboratories group of companies. The SPIRIT Clinical Program is sponsored by Abbott.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward- looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, product performance, competitive offerings, procedural volume, overall market size and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with oth
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
2. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
3. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
4. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
5. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
6. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
7. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
8. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
9. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
10. Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
11. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Nov. 20 BD (Becton, Dic... the completion of its acquisition of HandyLab, In...lops and manufactures molecular diagnostic assays ...d HandyLab announced an exclusive agreement for BD...the HandyLab Jaguar(TM) platform, the first fully ...
(Date:11/19/2009)... 19 Warner Chilcott plc (Nasdaq: ...ly announced secondary offering of 20,000,000 of i....25 per share. The selling shareholders include f...rchant Banking, J.P. Morgan Partners (advised by C...tain other institutional investors and members of ...
(Date:11/19/2009)...v. 19 In a series of new... Heska Corporation (Nasdaq: HSKA ) ("Heska" or th... and improved website. The upgraded site is the r...ogramming to align the site with the company,s new...o: http://www.newscom.com/cgi-bin/prnh/20000622/...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3AgeEsteem 28R 29 Launches New Web Site Blog and How To Book 47496 1AgeEsteem 28R 29 Launches New Web Site Blog and How To Book 47496 2AgeEsteem 28R 29 Launches New Web Site Blog and How To Book 47496 3Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 1Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 2Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 3When Lawn Mowers Attack 3A National Medical Societies Offer Tips to Prevent Injuries 3B Children Often Victims 47490 1When Lawn Mowers Attack 3A National Medical Societies Offer Tips to Prevent Injuries 3B Children Often Victims 47490 2When Lawn Mowers Attack 3A National Medical Societies Offer Tips to Prevent Injuries 3B Children Often Victims 47490 3When Lawn Mowers Attack 3A National Medical Societies Offer Tips to Prevent Injuries 3B Children Often Victims 47490 4
...DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass., March 31...Eli Lilly and Company (NYSE: LLY ) and Alkermes,...esults from DURATION-2, the second in a series of ...ide once weekly, an investigational diabetes thera... , This 26-week clinical study compared exenatide ...
...y Use of INTEGRILIN(R) Investigational Dosing is N... with High-Risk Acute Coronary Syndrome, Study Fin...esented today at the 58th annual Scientific Sessio...taneously published by The New England Journal of ...ng an upstream, investigational dose of INTEGRILIN...
Other Medicine Technology:Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study 2Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study 3Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study 4Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study 5Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study 6Schering-Plough Announces Results of the Early ACS Trial 2Schering-Plough Announces Results of the Early ACS Trial 3Schering-Plough Announces Results of the Early ACS Trial 4Schering-Plough Announces Results of the Early ACS Trial 5Schering-Plough Announces Results of the Early ACS Trial 6
(Date:11/20/2009)..., , ST. LOUIS, Nov. 20 /PRNewswire-First...y announced that it will present at the Bank of Am...held December 2-3, 2009, at the Crowne Plaza Hotel... present Wednesday, December 2nd at 8:30 a.m. East...ay access a live, audio webcast of Centene,s prese...
(Date:11/20/2009)..., , LAS VEGAS, Nov. 20 /PRNewswire-USNewswir...y, Executive Director of the Nevada Health Care As...on (NHCA) commends and thanks Senate Majority Lead...ion a step closer toward our goal of protecting ev...ing home care, and preserving the strength and via...
(Date:11/20/2009)... Long durations of exposure to formaldehyde used ...ted with an increased risk of death from myeloid l... November 20 in the Journal of the National Cance...ss mortality from lymphohematopoietic malignancies... funeral industry workers, all of whom may have wo...
(Date:11/20/2009)... Based out of Dallas, TX,...he same quality products that are made in the USA....ember 20, 2009 -- blue sky scrubs is an independen...the quality, design, production and distribution o...ently only selling their products via their online...
(Date:11/20/2009)...Canadian study finds more severe cases than with s...Day News) -- Canadian researchers are reporting th... severe cases of H1N1 flu than seasonal flu. , ...factor for admission with pandemic H1N1 influenza,... samples," wrote Dr. Upton Allen and fellow resear...
Breaking Medicine News(10 mins):Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2
... study done in Pakistan has shown that handwashing.../which are diarrhoea and acute lower respiratory...entified to cause millions of deaths of children...tudy done in the squatter settlements in Karachi...
... new study by investigators from Sahlgrenska Unive... study on the factors and outcomes of the health c...rug induced liver disease happens with some medica...n made by Dr. Hyman Zimmerman and also called Hy's...
...ecent study has shown that Anorexia occurs in pers...ciousness. Researchers have found that eatin... occurs one in ten people. The reasons for this di...er is not aware of its own accurate body shape – ‘...
...atna, July 16 (IANS) Five patients have died amid ...llege// and Hospital (PMCH), which entered its thi...wo patients died Saturday while three others died ... real victims of the strike because there is no do...
...rostate cancer is one of the biggest cancer killer...500,000 men worldwide every year. This number is e...ompting increasing focus on prevention. Researcher... for prostate cancer progression in some men. ...
...nherited mutation in gene ENPP1 may contribute to ...Dr. Philippe Froguel from the Institute of Pasteur...s from the Imperial College of London, Britain rec...ed children. The results of the study showed tha...
Other Medicine News:Health News:Eating disorder occurs due to increased weight consciousness 2Health News:Tackling Prostate Cancer With A New Dietary Supplement 2
JSZ Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear
...re rigid gas permeable contact lenses used for cor...y corrects nearsightedness (myopia). The patient w...es them upon wakening. During the day, nearsighted... CRT and Quadra RG contact lenses apply slight pre...
... for a way to help your patients with chronic angi...the outcomes of several thousand cardiac patients ...proved the quality of their lives; it has allowed ... , ,MedCath Diagnostics, LLC, a national provider ...
Modular Cardiac Cath Labs
Medicine Products: